Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records
Year: 2019
Type: article
Study design: Observational Study
Source: JACC. Clinical electrophysiology
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Foundation for the National Institutes of Health, Doris Duke Charitable Foundation, American Heart Association, Boehringer Ingelheim, Abbott Laboratories, Bristol-Myers Squibb, Pfizer, Bayer, Novartis, Massachusetts General Hospital, Quest Diagnostics, National Institutes of Health, Philips Oral Healthcare, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke
Awards: Precision Medicine in Ischemic Stroke and Atrial Fibrillation (PreMISe-AF), American Heart Association Tobacco Regulation and Addiction Center (A-TRAC), Sequencing Annotation and Functional Analysis in Risk of Intracerebral Hemorrhage, AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses, Clinical and genetic prediction of lifetime risk of atrial fibrillation and its complications, Determining the Role of the Potassium Channel, KCNN3, in Atrial Fibrillation, G4873532901, G5577002218, G6036198799, Advancing Atrial Fibrillation Precision Medicine, Leveraging Genomics to Identify Causal Risk Factors for Atrial Fibrillation, Mentoring in Arrhythmia Research, G8155099957, G8206805072, IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL, Integrated, Multidisciplinary Training in Cardiovascular Research, Genomics of Cardiac Arrhythmias, Genetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel Disease, American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
OpenAlex ID: W2978962447
